Participants diagnosed with SYNGAP1-ID or PMD had significantly elevated scores in bedtime resistance, sleep anxiety, sleep-onset delay, night-time awakenings, parasomnias and sleep duration. Here, SYNGAP1 is linked to Pelizeaus-Merzbacher spectrum disorder.